Arkansas AG sues three big pharma companies for driving up the cost of insulin

Three massive pharmaceutical companies are facing a lawsuit in Arkansas over allegations they helped drive up the cost of insulin in the state – just as discussions over potential insulin price caps heat up nationwide.

Leslie Rutledge, attorney general of the Razorback state, announced the lawsuit on Wednesday, targeting Eli Lilly, based in Indianapolis, Indiana, Novo Nordisk, a Danish company, and Sanofi, from France.

The price of insulin has famously soared in recent years, making the drug that many diabetics need to manage their condition daily the poster-child for the crisis of American drug pricing.

Reigning in the price of insulin has even developed into a rare issue with bipartisan support, with both Republicans – like Rutledge – and Democrats – like President Joe Biden and Senator…